Information  X 
Enter a valid email address

Imperial Brands PLC (IMB)

  Print      Mail a friend       Annual reports

Tuesday 13 August, 2019

Imperial Brands PLC

Transaction in Own Shares

RNS Number : 9393I
Imperial Brands PLC
13 August 2019
 

Transaction in own shares

Imperial Brands plc (the "Company") announces that on 13 August 2019 it purchased for cancellation the following number of its ordinary shares of 10 pence each pursuant to its GBP 200 million share repurchase programme, details of which were announced on 10 July 2019

Description of shares: Imperial Brands plc - ordinary shares of 10 pence

Number of shares repurchased: 200,000

Date of transaction: 13 August 2019

Average price paid per share: GBP 20.866095

Lowest price paid per share: GBP 20.68

Highest price paid per share: GBP 21.08

Broker: Barclays Capital Securities Limited

The Company intends to cancel these Shares.

Following the purchase and subsequent settlement and cancellation of these shares, the remaining number of ordinary shares in issue will be 954,383,719.

The figure of 954,383,719 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), detailed information about the individual purchases is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9393I_1-2019-8-13.pdf

 

For further information, please contact:

 

Imperial Brands plc

 

Peter Durman   

+44 (0)7970 328 093

Matt Sharff

+44 (0)7964 110 921

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSLLFVRTVIVLIA

a d v e r t i s e m e n t